HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hailong Cheng Selected Research

eslicarbazepine acetate

1/2019Serum sodium levels and related treatment-emergent adverse events during eslicarbazepine acetate use in adults with epilepsy.
1/2019Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures.
11/2018Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures.
1/2018Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures.
12/2017Incidence of seizure exacerbation and seizures reported as adverse events during adjunctive treatment with eslicarbazepine acetate: A pooled analysis of three Phase III controlled trials.
1/2016Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial.
4/2015Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a randomized historical-control phase III study based in North America.
3/2015Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study.
2/2015Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hailong Cheng Research Topics

Disease

11Seizures (Absence Seizure)
01/2019 - 02/2015
2Sleepiness
01/2020 - 01/2016
2Dizziness (Lightheadedness)
11/2018 - 01/2016
1Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2020
1Schizophrenia (Dementia Praecox)
01/2020
1Psychotic Disorders (Schizoaffective Disorder)
01/2020
1Hyponatremia
01/2019
1Epilepsy (Aura)
01/2019
1Headache (Headaches)
11/2018
1Vertigo (Positional Vertigo)
11/2018
1Vomiting
11/2018
1Diplopia (Double Vision)
11/2018
1Cardiac Arrhythmias (Arrythmia)
11/2008
1Chronic Obstructive Pulmonary Disease (COPD)
11/2008
1Body Weight (Weight, Body)
09/2002
1Acquired Immunodeficiency Syndrome (AIDS)
09/2002

Drug/Important Bio-Agent (IBA)

9eslicarbazepine acetateIBA
01/2019 - 02/2015
5Anticonvulsants (Antiepileptic Drugs)IBA
01/2017 - 02/2015
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
01/2020
1Trace amine-associated receptor 1IBA
01/2020
1Serotonin (5 Hydroxytryptamine)IBA
01/2020
1SEP-363856IBA
01/2020
1Antipsychotic Agents (Antipsychotics)IBA
01/2020
1Pharmaceutical PreparationsIBA
01/2020
1SodiumIBA
01/2019
1Carbamazepine (Tegretol)FDA LinkGeneric
11/2018
1Voltage-Gated Sodium Channel BlockersIBA
11/2018
1Lamotrigine (Lamictal)FDA LinkGeneric
11/2018
1Formoterol Fumarate (Oxis)FDA Link
11/2008
1Adrenergic Agents (Adrenergic Drugs)IBA
11/2008
1Salmeterol Xinafoate (Serevent)FDA Link
11/2008
1Saquinavir (Invirase)FDA Link
09/2002
1Indinavir (Crixivan)FDA Link
09/2002

Therapy/Procedure

2Therapeutics
01/2019 - 02/2015
1Salvage Therapy
09/2002